Byetta Injection
Product Images NDC 0310-6524

Product Visual Gallery

This gallery contains 100 technical images submitted to the FDA as part of the official labeling for Byetta (NDC 0310-6524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5mcg Cannot Be Pushed In

Byetta 250 mcg/mL injection, a human prescription drug containing exenatide, is presented in this image. The packaging is for subcutaneous use and labeled by AstraZeneca Pharmaceuticals LP. The image shows a small vial or cartridge container typically used for injection.*

FDA Label Image

5mcg Window

Byetta 250 micrograms/mL subcutaneous injection carton and vial label showing the product name, strength, injection dosage form, and AstraZeneca Pharmaceuticals LP as the labeler. The packaging is primarily white with black and gray text, including dosage instructions and storage information.*

FDA Label Image

Arrow For Dose Knob

Byetta 250 micrograms per milliliter subcutaneous injection carton and pen injector device. The packaging displays the Byetta brand name prominently, with the active ingredient exenatide indicated. The labeler AstraZeneca Pharmaceuticals LP is shown. The carton and pen injector are designed for prescription use.*

FDA Label Image

Arrow In Dose Window Cannot Be Pushed In

Byetta 250 mcg/mL injection carton and vial label displaying the product name, active ingredient exenatide, dosage form as injection for subcutaneous use, and the labeler AstraZeneca Pharmaceuticals LP. The carton shows the vial count and concentration, with consistent branding colors and layout.*

FDA Label Image

Arrow Knob Wont Turn

Byetta 250 mcg/mL injection label, a subcutaneous human prescription drug by AstraZeneca Pharmaceuticals LP. The label includes drug information, warnings, dosage details, and handling instructions. It features a blue and white design with text highlighting the active ingredient exenatide.*

FDA Label Image

Injection Arrow

Byetta 250 microgram/mL injection carton and pen injector kit labeled for subcutaneous use. The label identifies the active ingredient as exenatide and shows the AstraZeneca Pharmaceuticals LP labeler. The packaging includes the pen injector device and mentions the Dosage strength clearly on the carton.*

FDA Label Image

Injection Complete Arrow

Byetta 250 mcg/mL Injection single-dose pen carton. The label shows the brand name Byetta and active ingredient exenatide, indicating a subcutaneous injection dosage form. The packaging is primarily white with text and design elements in teal and gray. AstraZeneca Pharmaceuticals LP is listed as the labeler.*

FDA Label Image

Note 5mcg

Byetta 250 mcg/mL injection carton and pen device label by AstraZeneca Pharmaceuticals LP. The subcutaneous injection product contains exenatide as the active ingredient in a 1.2 mL single-use/pen format. The packaging shows dosing instructions, storage information, and branding details.*

FDA Label Image

Pull Dos 5mcg

Byetta 250 mcg/mL injection carton and pen device label showing the brand name Byetta and active ingredient exenatide. The packaging is white with red accents, indicating the subcutaneous injection dosage form. The labeler AstraZeneca Pharmaceuticals LP is visible on the packaging.*

FDA Label Image

Pull Out Arrow

Byetta 250 microgram per milliliter subcutaneous injection carton and glass vial packaging. The product is labeled as exenatide injection by AstraZeneca Pharmaceuticals LP. Visible on the carton are instructions and warnings, with a predominantly teal and white color scheme and a curved, multicolored accent. The vial label matches the product information with readable concentration details and barcode.*

FDA Label Image

Reset 5mcg Arrow

Byetta 250 microgram per mL injection carton label, a subcutaneous prescription drug containing exenatide. The label displays the brand and generic names, strength, dosage form, and AstraZeneca Pharmaceuticals LP as the labeler. Packaging includes warnings and usage instructions typical for an injectable medication.*

FDA Label Image

Step 3 Arrow 5mcg

Byetta 250 mcg/mL injection carton labeled with the brand and generic name exenatide. The label indicates it is a human prescription drug for subcutaneous use. The manufacturer is AstraZeneca Pharmaceuticals LP. The package includes product identification and strength information in a vertical, multi-color design.*

FDA Label Image

Step 3 Arrow Dose 5mcg

Byetta 250 mcg/mL injection pen carton and pen device, a subcutaneous injection pharmaceutical product containing exenatide. The packaging includes the brand name, dosage strength, and manufacturer, AstraZeneca Pharmaceuticals LP. The carton also displays usage instructions and vial graphics, and the device is a multi-dose pen for self-administration.*

FDA Label Image

Step E Arrow 5mcg

Byetta 250 mcg/mL injection pen packaging label, subcutaneous use. The label shows the brand name Byetta and indicates the solution concentration as 250 micrograms per milliliter. It is a human prescription drug manufactured by AstraZeneca Pharmaceuticals LP. The packaging is a small paper carton primarily in white, blue, and orange colors.*

FDA Label Image

Turn Dos 5mcg

Byetta 250 mcg/mL injection label for subcutaneous use. The label prominently displays the brand name Byetta and the strength of 250 mcg/mL. It is manufactured by AstraZeneca Pharmaceuticals LP. The product is intended for human prescription use and comes in an injection form.*

FDA Label Image

Turn Dose 5mcg 01

An instructional illustration showing a close-up of a finger pressing the dose button on the end of a Byetta injection pen, highlighting the number 5 dose setting and the rotation direction indicated by a blue arrow.*

FDA Label Image

Turn Knob Away Arrow

Byetta 250 mcg/mL injection for subcutaneous use, manufactured by AstraZeneca Pharmaceuticals LP. The image shows a carton box labeled with the proprietary name Byetta and strength 250 mcg/mL.*

FDA Label Image

Figure 1 (Byetta 01)

A line graph showing insulin secretion rate (pmol/kg/min) over time (minutes) split into first-phase and second-phase insulin responses. The graph compares responses after an IV glucose bolus at 0 minutes in three groups: BYETTA (Type 2 Diabetes, N=13), Glucose (Type 2 Diabetes, N=13), and Saline (Healthy, N=12). Error bars indicate variability among participants.*

FDA Label Image

Figure 2 (Byetta 02)

A line graph comparing plasma glucose levels (mg/dL) over time (minutes) after subcutaneous injection of Byetta (exenatide) versus placebo. The graph includes data points from 0 to 240 minutes, showing a decrease in plasma glucose for Byetta recipients and a higher trend for placebo. Markers indicate administration of subcutaneous injection and standardized breakfast timing.*

FDA Label Image

Figure 3 (Byetta 03)

This image contains two line graphs depicting the pharmacodynamic effects of Byetta (exenatide) injection compared to placebo over time. The top graph shows serum insulin levels (µU/mL) increasing sharply after injection with Byetta, while placebo remains relatively steady. The bottom graph displays plasma glucose levels (mg/dL) decreasing markedly after Byetta injection versus a slower decline with placebo, both measured over an 8-hour period.*

FDA Label Image

Byetta Parts (Byetta 05)

Illustration of the Byetta pen parts for exenatide 250 mcg/mL injection by AstraZeneca Pharmaceuticals LP. The pen components shown include the blue pen cap, cartridge containing Byetta liquid, label, dose window displaying a dose of 5, dose knob, and injection button. The image serves to identify the parts of the Byetta subcutaneous injection pen device.*

FDA Label Image

Byetta Pen Parts And Dose Window Symbols (Byetta 06)

Illustration diagram showing parts of a pen needle (outer needle shield, inner needle shield, needle, paper tab) with a note that pen needles are not included. The diagram also includes dose window symbols used for injection dosing: ready to pull dose knob out, ready to turn to dose position, ready to inject 5 mcg, and dose knob pushed in and ready to reset.*

FDA Label Image

Remove Paper From Needle (Byetta 09)

An instructional illustration showing hands preparing a Byetta (exenatide) 250 mcg/mL subcutaneous injection pen. The image depicts one hand holding the pen while the other hand is twisting or attaching part of the pen, likely illustrating the process of preparing the pen for injection.*

FDA Label Image

Pull Off Outer Needle (Byetta 10)

An instructional illustration showing a person removing a protective cap from the needle of a prefilled syringe injection pen, likely for subcutaneous use. The syringe contains medication, and the image visually guides on needle preparation before injection.*

FDA Label Image

Pull Off Inner Needle Shield (Byetta 11)

An instructional illustration showing a close-up of a hand removing a purple protective cap from the needle of a syringe. This image is likely related to the preparation of Byetta (exenatide) 250 mcg/mL subcutaneous injection for use.*

FDA Label Image

Arrow 4 (Byetta 17)

Byetta 250 mcg/mL injection label for subcutaneous use. The image shows a vial label with the proprietary name Byetta and the generic name exenatide. It is manufactured by AstraZeneca Pharmaceuticals LP. The label includes dosage strength information and appears designed for prescription use.*

FDA Label Image

Point Needle Away From You (Byetta 18)

An illustration showing a hand holding a Byetta injection pen pre-filled with exenatide 250 mcg/mL for subcutaneous use, demonstrating the injection device ready for administration.*

FDA Label Image

Push And Hold (Byetta 19)

An instructional illustration showing a hand holding a Byetta injection pen close to the skin, with an arrow indicating the injection site and an icon indicating to hold for 5 seconds. This diagram demonstrates proper subcutaneous injection technique for Byetta (exenatide) 250 mcg/mL injection by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Pen Preparation (Byetta 20)

Byetta 250 mcg/mL injection, subcutaneous, proprietary label showing a close-up of the dial window set to dose 5. The image depicts part of the pen device used for administering exenatide, labeled by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Check Pen Label (Byetta 22)

Instructional image showing a person holding and preparing to assemble a Byetta 250 mcg/mL injection pen for subcutaneous use. Hands are depicted with one hand holding the pen and the other hand holding the pen cap being removed in preparation for injection.*

FDA Label Image

Check Cartridge (Byetta 23)

An instructional illustration showing a hand holding a Byetta (exenatide) 250 mcg/mL subcutaneous injection pen. The image highlights the injection pen preparation or administration step with a blue arrow indicating a part of the device to interact with.*

FDA Label Image

Check Window Dose (Byetta 27)

Byetta 250 mcg/mL subcutaneous injection pen showing a close-up of the dose selector window displaying the dose number 5. The pen is orange with white ends and is produced by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Pull Dose Knob (Byetta 28)

An instructional diagram showing a close-up of a Byetta injection pen with an arrow pointing to the injection button and the dose number window displaying the number 5. The figure demonstrates how to use the pen for subcutaneous injection.*

FDA Label Image

Grip Pen Firmly (Byetta 30)

Photograph showing a person administering a subcutaneous injection using a Byetta injection pen. The image depicts hand positioning and injection technique for the 250 microgram per milliliter exenatide injection by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Push And Hold (Byetta 31)

An instructional illustration showing a person holding a Byetta injection pen with the label strength 250 mcg/mL visible. The image includes a labeled circle indicating 5 seconds, suggesting a step in the injection process. An arrow points to the injection pen's button or end to highlight pressing or activating action for Byetta, exenatide subcutaneous injection from AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Injection Is Complete (Byetta 32)

Byetta 250 micrograms per milliliter injection packaging label segment showing a blue and orange design with the number 5 prominently displayed and a small black arrow symbol centered within a clear plastic window.*

FDA Label Image

Turn Dose Window (Byetta 33)

An instructional illustration showing a close-up of a Byetta (exenatide) injection pen. The image focuses on the dial mechanism set to the number 5 and a finger pressing or turning the top of the pen, suggesting dose selection or injection preparation steps for subcutaneous administration.*

FDA Label Image

Carefully Put The Outer Needle (Byetta 34)

An instructional illustration showing a subcutaneous injection pen with an orange cap, a clear barrel marked with dosage measurements, and a white protective cap pointed at by a blue arrow, indicating removal or attachment.*

FDA Label Image

Unscrew The Needle (Byetta 35)

An illustration showing a hand holding a Byetta (exenatide) injection pen with the cap removed, demonstrating preparation or use of the subcutaneous injection device. The Byetta pen is orange with a label displaying the product name and dosage.*

FDA Label Image

Throw Away Needles (Byetta 36)

Byetta 250 mcg/mL injection in a pre-filled pen device for subcutaneous use. The device is labeled with dosing information and the AstraZeneca Pharmaceuticals LP logo. The image shows a hand holding the pen, emphasizing its user-friendly design for self-administration.*

FDA Label Image

Where To Inject Byetta (Byetta 37)

An illustration showing injection sites for Byetta (exenatide) 250 mcg/mL subcutaneous injection. Front view highlights the abdomen and front thighs as injection areas. Back view highlights the upper arms as injection sites.*

FDA Label Image

2.4 mL Cartridge Carton (Byetta 70)

Byetta 250 mcg/mL injection label showing a prefilled pen delivering 10 mcg per dose with 60 doses per pen. The label indicates subcutaneous use, refrigeration requirements, and that the pen needles are not included. The product is by AstraZeneca Pharmaceuticals LP for single patient use.*

FDA Label Image

1.2 mL Cartridge Carton (Image 01)

Byetta 250 mcg/mL subcutaneous injection prefilled pen label. The label shows a single-use pen delivering doses of 5 mcg each, with a 1.2 mL volume. It includes warnings for refrigeration, disposal instructions, and notes that pen needles are not included. The product is by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 02

Byetta 250 mcg/mL subcutaneous injection pen device shown in blue and orange colors. The pen is prefilled, intended for subcutaneous use, and labeled with the number 5 near the injection button. Manufactured by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 03

An instructional illustration showing a person holding an orange Byetta injection pen and removing the blue protective cap, demonstrating preparation of the exenatide 250 mcg/mL subcutaneous injection pen by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 04

An instructional diagram showing a close-up of a hand holding an orange Byetta (exenatide) 250 mcg/mL subcutaneous injection pen. The image demonstrates the step of removing the protective cap from the injection pen prior to use.*

FDA Label Image

Image 05

Byetta 250 micrograms per milliliter subcutaneous injection pen showing a close-up of the dosage window indicating a dose of 5. The device is primarily orange with a small rectangular window displaying the dose number. Labeler is AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 06

Illustration showing the injection tip of a Byetta 250 mcg/mL pen injector. The image highlights the injection interface with a numbered label '5' and a finger pressing the top mechanism, demonstrating the administration process of the subcutaneous injection.*

FDA Label Image

Image 07

An instructional illustration showing a close-up of a hand twisting the orange cap of a Byetta (exenatide) subcutaneous injection pen, highlighting the dose selection window displaying the number 5.*

FDA Label Image

Image 08

An instructional illustration showing how to attach or remove a needle cover on a Byetta injection pen. The image depicts hands holding the pen and twisting the needle cover in a clockwise and counterclockwise direction as indicated by the blue arrows.*

FDA Label Image

Image 09

An instructional illustration showing a hand holding a needle cap, positioned to remove it from a syringe. The syringe is prefilled, with a purple needle visible at the tip. The image demonstrates the step of preparing a subcutaneous injection, likely for Byetta (exenatide) 250 mcg/mL.*

FDA Label Image

Image 10

An instructional illustration showing a person's hand attaching a purple needle cap to a syringe, demonstrating preparation for subcutaneous injection.*

FDA Label Image

Image 11

An instructional diagram showing a close-up of a Byetta injection pen with a thumb turning a dial to select the dose '5'. Blue arrows indicate the direction for adjusting the dose on the 250 mcg/mL subcutaneous injection device by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 12

Byetta 250 mcg/mL injection pen device for subcutaneous administration is shown. The pen is primarily yellow with a blue cap and end, marked with the number 10 near the dosing window. The device is labeled by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 13

An instructional diagram showing the parts of a Byetta injection pen for subcutaneous use. The labeled components include the blue pen cap, cartridge containing Byetta liquid, label, dose window, dose knob, and injection button. The diagram is color-coded and titled 'BYETTA PEN PARTS.'*

FDA Label Image

Image 14

Illustration showing parts of a pen needle for injection, including the outer needle shield, inner needle shield, needle, and paper tab. It also explains dose window symbols indicating various stages of dose preparation and injection, such as pulling the dose knob out, turning to the dose position, injecting 10 mcg, and resetting the dose knob.*

FDA Label Image

Image 15

An instructional illustration showing the preparation of Byetta (exenatide) 250 mcg/mL subcutaneous injection. It depicts a person holding the pen injector and a separate cartridge or needle, with arrows indicating how to connect the components before use.*

FDA Label Image

Image 16

An instructional illustration showing a hand holding a yellow injection device for Byetta (exenatide) 250 mcg/mL subcutaneous injection. A blue arrow points to the needle end of the device, indicating part of the injection or preparation process.*

FDA Label Image

Image 17

An instructional diagram illustrating the process of preparing a Byetta (exenatide) 250 mcg/mL injection pen for subcutaneous use. The image shows a hand twisting off a protective yellow cap from the pen, indicating the first step in the injection preparation.*

FDA Label Image

Image 18

An instructional illustration showing a hand removing a protective cap from a subcutaneous injection pen, demonstrating the preparation step before administering Byetta (exenatide) injection 250 mcg/mL by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 19

An instructional illustration showing a hand removing the protective cap from the needle of a syringe filled with medication. A blue arrow indicates the direction to pull the cap off. The syringe is prefilled and marked with dosage measurements.*

FDA Label Image

Image 20

Byetta 250 mcg/mL injection pen label segment showing dose selector window set at dose number 10. The pen is yellow with a white cap, designed for subcutaneous use. Labeler is AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 21

An instructional illustration showing a close-up of a Byetta injection pen. The image highlights a blue button at the pen's end, with an arrow indicating the action of pressing the button with a thumb, demonstrating part of the injection process for the 250 mcg/mL exenatide subcutaneous injection pen by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 22

Instructional diagram showing a finger pressing a yellow Byetta injection pen with a visible blue dosage indicator set to 10. An arrow indicates the direction of pressing to activate or use the injection pen.*

FDA Label Image

Image 23

FDA Label Image

Image 24

Byetta 250 mcg/mL injection in a multi-dose pen device with a teal cap. The label includes dosage instructions and AstraZeneca Pharmaceuticals LP as the manufacturer, designed for subcutaneous use.*

FDA Label Image

Image 25

Byetta 250 micrograms per milliliter injection in a prefilled syringe. The carton displays the brand name Byetta and the active ingredient exenatide. The product is labeled for subcutaneous use and is manufactured by AstraZeneca Pharmaceuticals LP. The package appears to contain one prefilled syringe.*

FDA Label Image

Image 26

Byetta 250 mcg/mL injection label containing exenatide. The label is white with black and red text, including dosage strength and route of administration as subcutaneous injection. Manufactured by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 27

Byetta 250 mcg/mL injection pen label showing an orange and white design with the proprietary name Byetta prominently displayed. The label includes the active ingredient exenatide, the dosage strength 250 mcg/mL, and the route of administration as subcutaneous injection. The labeler is AstraZeneca Pharmaceuticals LP. The pen is designed for human prescription use.*

FDA Label Image

Image 28

An instructional illustration showing a hand holding a Byetta injection pen, used for subcutaneous administration. The pen is yellow and white with a clear cap, designed for delivering 250 mcg/mL exenatide dose for human prescription use, manufactured by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 29

An instructional illustration showing a hand holding a pen-like injection device with an arrow pointing upward, indicating the direction to hold or move the device. To the right, there is a circular graphic with the text '5 seconds,' likely indicating the recommended injection time or duration for the procedure.*

FDA Label Image

Image 30

Byetta 250 micrograms per milliliter subcutaneous injection cartridge, showing a labeled single cartridge partially enclosed in packaging. The label includes the number '10' in large print on a yellow background and a central area with an arrow symbol within a transparent window. Manufactured by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 31

Byetta 250 micrograms/mL injection carton and vial label. The packaging is primarily red, showing the proprietary name Byetta prominently. The dosage form is subcutaneous injection. Labeled by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 32

An instructional illustration showing a close-up of a thumb pressing a blue release button on a Byetta injection pen, labeled with the number 10, indicating dose adjustment or administration technique for the exenatide 250 mcg/mL subcutaneous injection pen by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 33

Byetta 250 mcg/mL injection carton and pen injector device shown. The product is a subcutaneous injection of exenatide, labeled by AstraZeneca Pharmaceuticals LP. The packaging is primarily white and blue with the product name and dosage visible on the carton and pen.*

FDA Label Image

Image 34

Instructional illustration showing two hands assembling a Byetta injection pen. One hand holds the blue pen cap, the other holds the yellow and blue pen body. A blue arrow indicates the pen cap should be attached to the pen body, demonstrating preparation of the exenatide 250 mcg/mL injection for subcutaneous use.*

FDA Label Image

Image 35

An instructional illustration showing hands holding a Byetta 250 mcg/mL injection pen. The image highlights the injection pen with a blue arrow pointing toward the needle cap at the tip, demonstrating preparation or injection technique for subcutaneous use.*

FDA Label Image

Image 36

An instructional illustration showing the assembly of a syringe-like injection device. The image depicts a hand attaching or adjusting a transparent cartridge or component at the end of the device, which features measurement markings and a yellow cap or plunger. This likely demonstrates part of the preparation or use of a subcutaneous injection for the Byetta (exenatide) product.*

FDA Label Image

Image 37

Instructional illustration showing a close-up of a hand removing a white protective cap from the needle of a syringe pen filled with exenatide injection (Byetta). The syringe pen is purple, indicating a subcutaneous injection device for the 250 mcg/mL strength medication.*

FDA Label Image

Image 38

An instructional illustration showing a hand placing a purple needle cap onto a syringe. The syringe is intended for subcutaneous injection and is likely related to the Byetta (exenatide) injection product by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 39

Byetta 250 mcg/mL injection pen showing a close-up of the dose selector window set to 10. The pen is yellow with a clear dose display area and an arrow indicating the dose adjustment. Labeled by AstraZeneca Pharmaceuticals LP for subcutaneous administration.*

FDA Label Image

Image 40

An instructional illustration showing how to remove the cap from a Byetta 250 mcg/mL injection pen. The image highlights gripping the pen with one hand and twisting or pulling the white cap with the other hand, indicated by a blue arrow.*

FDA Label Image

Image 41

Byetta 250 mcg/mL injection vial label showing the drug name, exenatide, as the active ingredient. The subcutaneous injection is provided in a single-dose vial with 1.2 mL volume. The label includes the AstraZeneca Pharmaceuticals LP logo and regulatory information.*

FDA Label Image

Image 42

An instructional illustration showing a finger gripping a pen injector labeled '10' with an arrow indicating a twisting motion, likely demonstrating how to adjust the dose or prepare the injection for the product Byetta (exenatide) 250 mcg/mL injection.*

FDA Label Image

Image 43

Byetta 250 micrograms per milliliter injection in a single-dose vial. The label features the product name and active ingredient exenatide, indicating subcutaneous use. Manufactured by AstraZeneca Pharmaceuticals LP, the design presents dosage information and vial content clearly for prescription use.*

FDA Label Image

Image 44

Byetta 250 mcg/mL injection packaging label for subcutaneous use. The label includes the proprietary name Byetta and notes the active ingredient exenatide. It displays use instructions, AstraZeneca Pharmaceuticals LP as the labeler, and contains detailed prescription drug information on the label.*

FDA Label Image

Image 45

Byetta 250 micrograms per milliliter (ug/mL) subcutaneous injection packaging label. The image shows a white and blue carton with the proprietary name Byetta prominently displayed, along with the strength 250 ug/mL. The labeler is AstraZeneca Pharmaceuticals LP. The package is designed for human prescription drug use.*

FDA Label Image

Image 46

Byetta 250 micrograms per milliliter (ug/mL) injection box by AstraZeneca Pharmaceuticals LP. The packaging is primarily white with purple and blue accents, featuring the Byetta brand name prominently, along with the drug's generic name exenatide, indicating the dosage strength and injection form for subcutaneous use.*

FDA Label Image

Image 47

Byetta 250 mcg/mL injection in a prefilled pen device, labeled for subcutaneous use. The product contains exenatide as the active ingredient and is manufactured by AstraZeneca Pharmaceuticals LP. The label includes dosage strength and administration instructions visible on the pen.*

FDA Label Image

Image 48

An instructional illustration showing a person administering a subcutaneous injection into the abdomen using a pen injector device. The injection pen is labeled with yellow and blue colors, consistent with Byetta (exenatide) 250 mcg/mL injection by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 49

An instructional illustration showing a person holding a Byetta injection pen labeled with the number 10. The image highlights a step involving pressing a blue button or cap, with a circular icon indicating to hold for 5 seconds, likely illustrating part of the injection process for Byetta 250 mcg/mL subcutaneous injection by AstraZeneca Pharmaceuticals.*

FDA Label Image

Image 50

The image shows a Byetta 250 mcg/mL subcutaneous injection pen. The visible portion includes the dosage window with a numeric indicator '10', suggesting a dose or unit display on the pen device. The product is by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 51

FDA Label Image

Image 52

FDA Label Image

Image 53

Byetta 250 mcg/mL injection vial label, featuring the proprietary name Byetta and the generic name exenatide. The label is primarily blue with a clear measurement scale on the vial showing 0 to 0.2 mL volume. The product is manufactured by AstraZeneca Pharmaceuticals LP for subcutaneous use.*

FDA Label Image

Image 54

Byetta 250 mcg/mL injection single-dose pen, a subcutaneous human prescription drug by AstraZeneca Pharmaceuticals LP. The image displays a box with the product name, strength, dosage form, and labeler information clearly visible in blue and white packaging.*

FDA Label Image

Image 55

Byetta 250 mcg/mL injection carton label showing the product name Byetta with the active ingredient exenatide. The label indicates it is a human prescription drug indicated for subcutaneous injection. The labeler is AstraZeneca Pharmaceuticals LP. The carton design includes blue and purple color elements.*

FDA Label Image

Image 56

Byetta 250 mcg/mL injection pen. The image shows a white and purple prefilled pen device designed for subcutaneous administration of exenatide. The pen is labeled with the brand name Byetta and has a dosage strength of 250 micrograms per milliliter. AstraZeneca Pharmaceuticals LP is the labeler.*

FDA Label Image

Image 57

An instructional diagram showing a close-up of a finger pressing a blue button on a yellow injector pen labeled with the number 10, demonstrating the injection technique or device usage for Byetta (exenatide) 250 mcg/mL subcutaneous injection by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Image 58

Byetta 250 microgram per milliliter injection for subcutaneous use. The packaging shows a green and black box with white text, featuring the brand name Byetta prominently along with its generic name exenatide. The labeler AstraZeneca Pharmaceuticals LP is identified.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.